Schalop Lee Troy 4
4 · Lantern Pharma Inc. · Filed Aug 20, 2025
Insider Transaction Report
Form 4
Schalop Lee Troy
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-08-19+5,000→ 5,000 totalExercise: $4.46Exp: 2035-08-18→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Equity Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing September 19, 2025.